PXD058209
PXD058209 is an original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer |
| Description | Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor prognosis and limited therapeutic options. In a previous publication, our group defined some of the mechanisms that vitamin D analogue paricalcitol (P) and hydroxychloroquine (H) potentiated the effects of gemcitabine-based chemotherapy in PDAC. Based on this, we hypothesized that the mechanisms of potentiation of 5-Fluorouracil (5FU) and oxaliplatin-based chemotherapy by PH may include different pathways than what was seen with gemcitabine-based therapy. Using MIA PaCa-2, HPAC and KPC cell lines, the combination of PH significantly increased the cell death, apoptosis, and S-phase cell cycle arrest. In vivo, the combination therapy inhibited PDAC growth and altered the immune landscape by activating T and NK cells. Proteomic analysis revealed that, significant reduction in ECM proteins, specifically integrin beta-4 (ITGB4) which was also seen with gemcitabine. Furthermore, genetic knockdown of ITGB4 suggested that the ECM inhibiti |
| HostingRepository | iProX |
| AnnounceDate | 2024-11-23 |
| AnnouncementXML | Submission_2024-11-24_21:22:03.749.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Dhana Bandi |
| SpeciesList | scientific name: Mus musculus; NCBI TaxID: 10090; |
| ModificationList | monohydroxylated residue |
| Instrument | Q Exactive HF-X |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
|---|---|---|---|
| 0 | 2024-11-24 21:21:38 | ID requested | |
| ⏵ 1 | 2024-11-24 21:22:04 | announced |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: proteomics, paricalcitol, hydroxychloroquine, 5-FU, Oxaliplatin, pancreatic ductal adenocarcinoma |
Contact List
| Bassel El-Rayes | |
|---|---|
| contact affiliation | University of Alabama at Birmingham |
| contact email | BELRAYES@UAB.EDU |
| lab head | |
| Dhana Bandi | |
| contact affiliation | University of Alabama at Birmingham |
| contact email | dsbandi@uab.edu |
| dataset submitter | |
Full Dataset Link List
| iProX dataset URI |




